{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:24:25Z","timestamp":1761765865018,"version":"3.40.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS","award":["26460464"],"award-info":[{"award-number":["26460464"]}]},{"DOI":"10.13039\/501100001631","name":"University College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.canlet.2014.11.055","type":"journal-article","created":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T20:17:55Z","timestamp":1417292275000},"page":"355-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like ATL cells in an NF-\u03baB- and vimentin-dependent manner"],"prefix":"10.1016","volume":"357","author":[{"given":"Yukiko","family":"Miyatake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Ikeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-6600","authenticated-orcid":false,"given":"Masanori","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2014.11.055_bib0010","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2014.11.055_bib0015","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1365-4632.2010.04568.x","article-title":"Cutaneous manifestations associated with HTLV-1 infection","volume":"49","author":"Bittencourt","year":"2010","journal-title":"Int. J. Dermatol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1349-7006.2007.00456.x","article-title":"Pathological features of diseases associated with human T-cell leukemia virus type I","volume":"98","author":"Ohshima","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.canlet.2014.11.055_bib0025","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/v3060750","article-title":"Controversies in targeted therapy of adult T cell leukemia\/lymphoma: ON target or OFF target effects?","volume":"3","author":"Nasr","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.canlet.2014.11.055_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","article-title":"Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting","volume":"27","author":"Tsukasaki","year":"2009","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/10428194.2013.807511","article-title":"No effect of humanized CCR monoclonal antibody (mogamulizumab) on treatment-resistant adult T cell leukemia with meningeal infiltration","volume":"55","author":"Tsutsumi","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.canlet.2014.11.055_bib0040","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrc1592","article-title":"Leukaemia stem cells and the evolution of cancer-stem-cell research","volume":"5","author":"Huntly","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.11.055_bib0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.11.055_bib0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nrc3023","article-title":"CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?","volume":"11","author":"Z\u00f6ller","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2014.11.055_bib0055","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/emboj.2011.211","article-title":"Direct reprogramming of stem cell properties in colon cancer cells by CD44","volume":"30","author":"Su","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2014.11.055_bib0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2011.01.038","article-title":"CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth","volume":"19","author":"Ishimoto","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2014.11.055_bib0065","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.leukres.2011.05.011","article-title":"Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia","volume":"35","author":"Chagan-Yasutan","year":"2011","journal-title":"Leuk. Res"},{"key":"10.1016\/j.canlet.2014.11.055_bib0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI200421358","article-title":"NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression","volume":"114","author":"Huber","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2014.11.055_bib0075","doi-asserted-by":"crossref","first-page":"17635","DOI":"10.1074\/jbc.M800109200","article-title":"Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells","volume":"283","author":"Bourguignon","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.canlet.2014.11.055_bib0080","doi-asserted-by":"crossref","first-page":"6584","DOI":"10.1073\/pnas.1113271109","article-title":"ErbB receptor tyrosine kinase\/NF-\u03baB signaling controls mammosphere formation in human breast cancer","volume":"109","author":"Hinohara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2014.11.055_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-007-9798-y","article-title":"NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells","volume":"111","author":"Zhou","year":"2008","journal-title":"Breast Cancer Res. Treat"},{"key":"10.1016\/j.canlet.2014.11.055_bib0090","first-page":"2360","article-title":"Constitutive activation of NF-kappaB in primary adult T-cell leukemia cells","volume":"93","author":"Mori","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2014.11.055_bib0095","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1593\/neo.03388","article-title":"Tax-independent constitutive IkappaB kinase activation in adult T-cell leukemia cells","volume":"6","author":"Hironaka","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2014.11.055_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1158\/0008-5472.CAN-10-3220","article-title":"Cancer stem cell niche: the place to be","volume":"71","author":"Borovski","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.11.055_bib0105","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1158\/0008-5472.CAN-05-3986","article-title":"Normal stem cells and cancer stem cells: the niche matters","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2014.11.055_bib0110","doi-asserted-by":"crossref","first-page":"346972","DOI":"10.1155\/2012\/346972","article-title":"Hyaluronan regulates cell behavior: a potential niche matrix for stem cells","volume":"2012","author":"Solis","year":"2012","journal-title":"Biochem. Res. Int"},{"key":"10.1016\/j.canlet.2014.11.055_bib0115","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2014.11.055_bib0120","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1007\/s11033-012-2376-3","article-title":"Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells","volume":"40","author":"Havasi","year":"2013","journal-title":"Mol. Biol. Rep"},{"key":"10.1016\/j.canlet.2014.11.055_bib0125","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/humrep\/deg290","article-title":"A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells","volume":"18","author":"Hovatta","year":"2003","journal-title":"Hum. Reprod"},{"key":"10.1016\/j.canlet.2014.11.055_bib0130","doi-asserted-by":"crossref","first-page":"e8067","DOI":"10.1371\/journal.pone.0008067","article-title":"Human induced pluripotent stem cells on autologous feeders","volume":"4","author":"Takahashi","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.11.055_bib0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-7-76","article-title":"Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?","volume":"7","author":"Catalina","year":"2008","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2014.11.055_bib0140","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nbt922","article-title":"Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells","volume":"22","author":"Draper","year":"2004","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0145","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.ajpath.2013.01.015","article-title":"Protective roles of epithelial cells in the survival of adult T-cell leukemia\/lymphoma cells","volume":"182","author":"Miyatake","year":"2013","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0150","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1083\/jcb.121.5.1141","article-title":"Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes","volume":"121","author":"Wayner","year":"1993","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0155","doi-asserted-by":"crossref","first-page":"e39065","DOI":"10.1371\/journal.pone.0039065","article-title":"Withaferin a alters intermediate filament organization, cell shape and behavior","volume":"7","author":"Grin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.11.055_bib0160","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2353\/ajpath.2006.051225","article-title":"Role of neuronal interferon-gamma in the development of myelopathy in rats infected with human T-cell leukemia virus type 1","volume":"169","author":"Miyatake","year":"2006","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.canlet.2014.11.055_bib0170","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.stem.2012.02.016","article-title":"Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells","volume":"10","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2014.11.055_bib0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","article-title":"NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells","volume":"22","author":"Bentires-Alj","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2014.11.055_bib0180","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bcp.2012.08.027","article-title":"Molecular insight in the multifunctional activities of withaferin A","volume":"84","author":"Vanden Berghe","year":"2012","journal-title":"Biochem. Pharmacol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0185","doi-asserted-by":"crossref","first-page":"e75069","DOI":"10.1371\/journal.pone.0075069","article-title":"Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.11.055_bib0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.chembiol.2007.04.010","article-title":"The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin","volume":"14","author":"Bargagna-Mohan","year":"2007","journal-title":"Chem. Biol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0195","doi-asserted-by":"crossref","first-page":"e10105","DOI":"10.1371\/journal.pone.0010105","article-title":"Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies","volume":"5","author":"Lahat","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2014.11.055_bib0200","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","article-title":"Vimentin in cancer and its potential as a molecular target for cancer therapy","volume":"68","author":"Satelli","year":"2011","journal-title":"Cell. Mol. Life Sci"},{"key":"10.1016\/j.canlet.2014.11.055_bib0205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.canlet.2014.11.055_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","author":"West","year":"2014","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.canlet.2014.11.055_bib0215","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.canlet.2014.11.055_bib0220","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J. Clin. Oncol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0225","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1182\/blood-2010-10-312603","article-title":"Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma","volume":"117","author":"Piekarz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2014.11.055_bib0230","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10585-008-9171-5","article-title":"Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression","volume":"25","author":"Hudson","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.canlet.2014.11.055_bib0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ajpath.2013.09.018","article-title":"Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma","volume":"184","author":"Gravelle","year":"2014","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.canlet.2014.11.055_bib0240","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ni.2547","article-title":"Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells","volume":"14","author":"G\u00e9rard","year":"2013","journal-title":"Nat. Immunol"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400740X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030438351400740X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T05:55:15Z","timestamp":1538027715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030438351400740X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S030438351400740X"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2014.11.055","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like ATL cells in an NF-\u03baB- and vimentin-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2014.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}